Introduction
The health status of dogs is strictly dependent on the proper concentration of major and trace elements in their body. Selenium is one of the most important of the many dietary factors that play a crucial role in immune function. The biological importance of this element is mainly due to its presence in selenium-dependent enzymes which play a key role in many metabolic processes. High selenium concentrations are found in blood-forming organs (liver, spleen), which probably has an effect on the hematopoietic processes. Mullally et al. [1] believe that the hematopoietic effect of this element may be associated with protection of organelles and cell membranes through antioxidant action, which translates into extended lifespan of red blood cells and leukocytes.
Over the last few years, many studies were performed to confirm or refute various hypotheses concerning the health consequences of selenium deficiency. Rayman [2] believes that there is a relationship between proper selenium supplementation and reduced risk of cancer. It has been suggested that selenium exerts anti-cancer activity through selenoenzymes, which detoxify reactive oxygen species. Steinbrenner and Sies [3] report that oxidative modifications of bases and DNA strand breaks are the underlying cause of many forms of neoplasms.
In small amounts, selenium contributes to the proliferation of cells important for immune response. An increasing number of recently reported studies are showing that selenium deficiency is associated with neoplastic and cardiovascular diseases. In high but nontoxic doses, selenium may reduce the risk of cancer by blocking tumour cell cycle, stimulating apoptosis, and inhibiting tumour cell migration [4] . Navarro-Alarcon et al. [5] report that low plasma selenium concentration is correlated with increased risk of cancer. The same authors showed much lower selenium concentrations in cancer patients compared to the control group. The antioxidant properties of selenium and glutathione peroxidase and their role in DNA protection are used in anti-cancer therapy [6] [7] [8] .
The aim of the study was to determine if there is a relationship between serum selenium concentration in dogs and their health, and to assess the relationship between selenium concentration and morphological parameters of blood.
Experimental Procedures
The study was conducted with 91 dogs of different breeds from Western Pomerania, Poland. Material for the study and data on the breeds, health status, sex, age and diets of the dogs were obtained from veterinary clinics in Szczecin and Stargard Szczeciński (northwestern Poland). Dogs were divided according to health status into 6 groups: healthy (n=14); with hip dysplasia (n=11); with non-malignant tumour (n=11); with malignant neoplasm (n=24); with allergy (n=16); and with bone fractures (n=15). Among the malignant neoplasms diagnosed were those of the milk line (n=5), mammary gland (n=3), reproductive system (n=3), bones (known as osteosarcoma) (n=4), skin (n=2), prostate (n=3), lymph nodes (lymphoma) (n=3) and liver (n=1). To determine the effect of diet on selenium concentration, dogs were divided into 3 groups, namely those fed home-made (n=16), commercial (n=30) and mixed food (n=45). In addition, dogs were classified according to breed and size as small (n=12, average body weight of 11.5±5.1 kg) and large (n=79, and average body weight of 36.8±10.6 kg). Animals were divided according to age into 4 groups: less than 1 year old (n=16), 1 to 5 years old (n=30), 5 to 9 years old (n=24), and more than 9 years old (n=21). The dogs studied, were mongrel dogs as well as Cocker Spaniels, Irish Setters, Gordon Setter, Dachshunds, American Staffordshire Terrier, Yorkshire Terrier, German Shepherds, Briards, Polish Tatra Sheepdogs, Dogues de Bordeaux, Labrador Retrievers, Bavarian Mountain Hounds, French Bulldog, Doberman Pinscher, Alaskan Malamute, and Golden Retriever.
Blood for analysis was collected during routine examination of dogs in veterinary facilities. The experiment complies with the current laws of Poland. Before blood collection, animals were examined clinically and, when necessary, additional laboratory tests were performed. Blood for analysis was collected from the cephalic vein into tubes without anticoagulant and left to coagulate at room temperature. After clotting, the samples were centrifuged and the serum obtained was separated and frozen at -20ºC until chemical analyses were conducted.
To determine selenium content, serum was wet mineralized in concentrated HNO 3 and HClO 4 , and later using 9% HCl. Selenium content was determined spectrofluorometrically using 2,3-diaminonaphthalene. Se was determined using the method described earlier [9] . Wavelength measurements were conducted at 518 nm using an excitation wavelength of 376 nm. The accuracy of the analytical method was based on reference material BCR-185R from the European Commission Joint Research Centre Institute for Reference Materials and Measurements (LGC Standards GmbH, Wesel, Germany). The Se concentration was 97.4±1.5% of the reference value.
A complete blood count was also performed. For this purpose, blood was collected into a tube containing K 3 EDTA as an anticoagulant. Hematological indices were determined using a SYSMEX F800 hematology analyser, following the manufacturer's instructions. Blood was analysed for red blood cell count (RBC), white blood cell count (WBC) and mean platelet count (MHC); hemoglobin concentration (HBC); hematocrit value (HCT); and red blood cell parameters (MCV -mean corpuscular volume, MCHC -mean corpuscular hemoglobin concentration, MCH -mean corpuscular hemoglobin). Selenium concentration was determined in serum obtained after centrifugation of whole blood.
Statistical calculations were performed using procedures of Statistica PL 9.0. Normal distribution was tested, data were log-transformed and statistical analysis was performed using log-transformed data. One-way analysis of variance was used and significant differences between the means were calculated with Tukey's test. The correlation between selenium concentration and morphological parameters were determined by calculating Pearson's coefficient of correlation.
Results
Serum selenium concentrations in the dogs are presented in Table 1 . Dogs diagnosed with malignant neoplasm showed a significantly lower mean serum selenium concentration compared to healthy dogs (P<0.01) and those from the other groups analysed, namely with hip dysplasia, allergy and fractures (P<0.01) and with non-malignant tumour (P<0.05). Healthy dogs were characterized by the highest mean serum selenium concentration, significantly (P<0.05) higher compared to dogs with non-malignant tumour, malignant neoplasm, allergy and fractures. Furthermore, dogs diagnosed with malignant neoplasm had a significantly (P<0.01) lower hematocrit value (HCT) compared to dogs with nonmalignant tumour, hip dysplasia and allergy, as well as significantly (P<0.05) lower mean corpuscular hemoglobin (MCH) compared to dogs with non-malignant tumour (Table 2) . Dogs diagnosed with allergy had the highest mean platelet count (PLT), significantly (P<0.05) higher than in dogs with hip dysplasia and non-malignant tumour.
Correlation analysis (Table 3) showed several significant relationships between serum selenium concentration and morphological parameters of blood in some of the animal groups investigated. In dogs diagnosed with non-malignant tumour, significantly high positive correlations were observed between selenium concentration and WBC (0.70; P<0.05), RBC (0.76; 
Discussion
In the dogs studied, serum selenium concentration was found to fall within the range of reference values (Table 1) , which in dogs vary between 0.150 and 0.340 mg/ml [10] . According to Simcock et al. [11] , no reports are available for cases of clinical selenium deficiency in dogs, which the authors believe to be caused by the fact that most dogs are fed commercial foods which usually contain sufficient levels of selenium to prevent deficiencies. In our study, we showed no significant (P<0.05) differences in Se serum content according to the type of animal food. In a study by Nicpoń et al. [12] , serum selenium concentration in dogs deviated considerably from the reference values depending on the type of food. The concentration averaged at 0.435 mg/ml (from 0.259 to 0.561 mg/ml) in dogs receiving commercial food, and 0.638 mg/ml (from 0.332 to 0.938 mg/ml) in dogs fed home-made food. In our study, mean serum concentrations in the analysed dogs were much lower and ranged from 0.169 to 0.273 mg/ml. There were also no differences in Se serum content between females and males, and in accordance with the age of Table 2 . Complete blood count of dogs from different study groups. animals. The results obtained agree with the findings of other authors [12, 13] . The high morbidity and mortality due to malignant neoplasms points to a considerable impact of environmental factors. A special role in this regard is attributed to the presence of trace elements (e.g. selenium) in the diet. As an antioxidant, selenium protects the body from the harmful effects of free radicals while increasing the activity of immune cells and inhibiting the growth of tumour blood vessels [2, [14] [15] [16] .
A… -same letters indicate statistically significant differences at P<0.01 a -same letters indicate statistically significant differences at P<0.05 WBC -white blood cell count, RBC -red blood cell count, HGB -mean hemoglobin concentration, HCT -hematocrit, MCV -mean corpuscular volume, MCH -mean corpuscular hemoglobin, MCHC -mean corpuscular hemoglobin concentration, PLT -platelet count
Rajca [17] reports that protective effects only occur when a threshold dietary level of selenium is exceeded and concerns the neoplasm site. Schrauzer et al. [18] observed an inverse correlation between dietary selenium intake and mortality due to cancers of the lung, large intestine, rectum, prostate, breast, and ovary. Duffield-Lillico et al. [19] demonstrated that not only cancer incidence but also cancer mortality decreased in a group of selenium-supplemented humans. The same authors found the protective effects to depend on baseline plasma selenium concentrations in seleniumsupplemented individuals and at cancer specific sites. Selenium supplementation decreased the risk of prostate, colorectal and lung cancer but increased the risk of breast cancer. Menkes et al. [20] showed that selenium supplementation in individuals with higher baseline selenium levels had no preventive effect in patients with cancer.
According to Waters et al. [21] , research on canine prostate cancer is considered a model for developing preventive programmes against prostate cancer in humans based on rational use of selenium. The authors showed that giving Se-supplemented food to dogs reduced prostate cancer risk by 63%. In our study, dogs diagnosed with malignant neoplasm had lower selenium concentrations compared to the control animals. Similar results were obtained by Pilarczyk et al. [13] , who found selenium concentrations to be lower in dogs with neoplasms. In vitro studies concerning the effect of Se on the development of mammary gland cancer cells in dogs showed that selenium had an inhibitory effect on these cells and supplemental vitamin C enhanced this effect [22, 23] . Cowie [24] takes the view that veterinarians suspecting neoplasm in dogs should pay special attention to serum selenium concentrations.
It has been noted that vitamin E and Se have a beneficial effect in heart diseases [25] and their prevention [26] , neuro-motor disorders [27] and myopathy [28] , and protect animals against atherosclerosis [29] .
Authors offer various explanations for anticarcinogenic effects of selenium. The possible mechanisms of selenium action include interfering with carcinogen metabolism, modifying the interaction between carcinogens and DNA, enhancing detoxification mechanism, increasing glutathione levels, modifying cell membrane permeability, selectively inhibiting the energy metabolism of cancer cells, and stimulating the body's immune function [2, 4, 6, 14, 17] .
In our study, we found significantly lower selenium concentrations in animals with allergies compared to the control animals, which can be attributed to disturbances in arachidonic acid metabolism. Reduced activity of glutathione peroxidase, which occurs with selenium deficiency, disturbs arachidonic acid metabolism and results in a disproportion in the concentration of its derivatives. This leads to increased production of 12-hydroxyeicosatetraenoic acid (12-HETE) and inhibits the degradation of 12-hydroxyperoxyeicosatetraenoic acid (12-HPETE). This situation enhances the synthesis of leukotriene, a substance which exhibits strong proinflammatory activity. The increased 12-HETE production is stimulated by platelet activating factor and free oxygen radicals that are produced in excess [30] . In our study, dogs diagnosed with allergy had the highest mean platelet count (PLT). Platelets play a key role during the inflammatory stage, and are responsible for hemostasis and release of signalling molecules which affect the developing inflammatory processes [31] .
In our study, the group of dogs with bone fractures showed a significantly lower concentration of selenium compared to the control group. Selenium deficiency has an effect on bone metabolism, as exemplified by KashinBeck disease (growth disturbances, joint deformities). A study by Moreno-Reyes et al. [32] with rats showed that growth retardation induced by selenium deficiency is associated with disturbed bone metabolism and osteopenia (a condition where bone mineral density is lower than normal). The decreasing bone mineral density is paralleled by a significant increase in the relative risk of fractures.
Low levels of selenium contribute to the incidence of neoplasms and allergies and increase the risk of bone fractures in dogs. Therefore, additional laboratory tests should be conducted when certain diseases are diagnosed to determine Se concentration in dogs, thus making it possible to take preventive measures (supportive treatment) or therapeutic action (selenium use).
